OptimizeRx (OPRX) Set to Announce Quarterly Earnings on Wednesday

OptimizeRx (NASDAQ:OPRX) is scheduled to be posting its quarterly earnings results after the market closes on Wednesday, November 13th. Analysts expect OptimizeRx to post earnings of $0.06 per share for the quarter. Individual interested in registering for the company’s earnings conference call can do so using this link.

OptimizeRx Trading Down 3.5 %

Shares of OptimizeRx stock opened at $6.06 on Tuesday. The firm has a market cap of $111.02 million, a price-to-earnings ratio of -6.06 and a beta of 1.32. The business has a 50-day moving average price of $6.81 and a 200-day moving average price of $9.12. The company has a quick ratio of 3.07, a current ratio of 3.07 and a debt-to-equity ratio of 0.27. OptimizeRx has a twelve month low of $5.04 and a twelve month high of $16.65.

Wall Street Analysts Forecast Growth

A number of research analysts have recently weighed in on the company. Royal Bank of Canada cut their price objective on OptimizeRx from $17.00 to $14.00 and set an “outperform” rating for the company in a research report on Friday, August 16th. Barclays dropped their price target on OptimizeRx from $15.00 to $11.00 and set an “equal weight” rating for the company in a research report on Monday, August 12th. Finally, B. Riley assumed coverage on OptimizeRx in a research report on Thursday, July 25th. They issued a “buy” rating and a $18.50 price target for the company. One analyst has rated the stock with a hold rating and four have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $14.50.

OptimizeRx Company Profile

OptimizeRx Corporation, a digital health technology company, enables care-focused engagement between life sciences organizations, healthcare providers, and patients at critical junctures throughout the patient care journey. It offers various tech-enabled marketing solutions through its Artificial Intelligence-generated Dynamic Audience and Activation Platform, which enables customers to execute traditional marketing campaigns on its proprietary digital point-of-care network, as well as dynamic marketing campaigns that optimize audiences in real time to increase the value of treatment information for healthcare professionals and patients in response to clinical care events.